S
SELLAS LIFE SCIENCES GROUP INC
NASDAQ: SLS (SELLAS Life Sciences Group, Inc)
Kemas kini terakhir: 1 jam lalu13.21
-2.00 (-13.15%)
| Penutupan Terdahulu | 15.21 |
| Jumlah Dagangan | 9,757,807 |
| Harga / Jualan (P/S) | 26.90 |
| Harga / Buku (P/B) | 22.32 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -0.360 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.13% |
| Nisbah Semasa (MRQ) | 4.64 |
| Aliran Tunai Operasi (OCF TTM) | -33.71 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -23.98 M |
| Pulangan Atas Aset (ROA TTM) | -58.79% |
| Pulangan Atas Ekuiti (ROE TTM) | -144.90% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | SELLAS Life Sciences Group, Inc | Bercampur | Menaik |
AISkor Stockmoo
1.2
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 4.0 |
| Purata | 1.17 |
|
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 0.34% |
| % Dimiliki oleh Institusi | 14.34% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Dagco, Inc. | 30 Jun 2026 | 1,232,433 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |